A groundbreaking study is taking a fresh look at one of science’s oldest questions: how did life arise from nonliving material on early Earth? Researcher Robert G. Endres of Imperial College London has created a new mathematical framework…
Blog
-
‘5 soldiers, 25 militants killed’: Pakistan reports fresh border clashes with Afghanistan; incident amid truce talks
Pakistan army on Sunday said that five of its soldiers and 25 militants were killed during border clashes with Afghanistan.These attacks occurred while Afghan and Pakistani officials met in Istanbul amid a recent ceasefire agreement.“These…
Continue Reading
-
The math says life shouldn’t exist, but somehow it does
A groundbreaking study is taking a fresh look at one of science’s oldest questions: how did life arise from nonliving material on early Earth? Researcher Robert G. Endres of Imperial College London has created a new mathematical framework…
Continue Reading
-
Sydney Sweeney Wears Custom Miu Miu at the ‘Christy’ Premiere during AFI Fest 2025
On Saturday, Sydney Sweeney graced the red carpet for the premiere of her forthcoming film “Christy” during the AFI Fest 2025, clad in a soft pink custom Miu Miu gown.
Styled by Molly Dickson, the “Euphoria” star,…
Continue Reading
-
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance – SciTechDaily
- How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance SciTechDaily
- Even for elite athletes, the body’s metabolism has its limits Science News
- How to Push Your Metabolic Ceiling – and Burn More Calories Without…
Continue Reading
-
PUBG and InZoi publisher Krafton declares itself an “AI-first company”, “placing AI at the centre of problem solving”
PUBG and Subnautica 2 publisher Krafton has declared itself an “AI-first company”, announcing a move to “place AI at the centre of problem solving” via a “complete” company reorganisation.
The megacorp outlined its “transition to…
Continue Reading
-
Novartis Avidity Biosciences in talks
Signage for Novartis AG at a building in the company’s headquarters campus in Basel, Switzerland, on Monday, Jan. 8, 2023.
Bloomberg | Bloomberg | Getty Images
Swiss pharmaceutical giant Novartis is nearing a deal to buy biotechnology company Avidity Biosciences for more than $70 a share, Bloomberg News reported, citing a person familiar with the matter.
A deal could be announced as early as Sunday, the report said.
Novartis and Avidity didn’t immediately respond to CNBC’s requests for comment.
Avidity specializes in developing an innovative class of ribonucleic acid (RNA) therapeutics called antibody oligonucleotide conjugates. RNA-based therapeutics are a relatively new class of medications that work by altering how genes are expressed to treat or prevent diseases.
The reported discussions come as Novartis ramps up its research and development division. The company earlier this year pledged to invest $23 billion to build out its U.S.-based infrastructure, which includes plans to construct a second R&D hub in San Diego.
The company has also struck two key deals with Anthos Therapeutics and Regulus Therapeutics this year to boost its development and manufacturing of cardiovascular and kidney disease drugs.
Avidity shares closed at $49.15 on Friday. The stock, which has a market capitalization of roughly $7.2 billion, is up nearly 70% since the beginning of the year. Novartis shares closed at $130.36 on Friday.
Read the complete Bloomberg News report here.
Continue Reading
-
Radiohead’s Thom Yorke says he won’t play Israel under Netanyahu, but slams BDS movement
Radiohead frontman Thom Yorke told the UK’s Sunday Times that he won’t play in Israel again while Prime Minister Benjamin Netanyahu is in power, and that Israel should not be part of Eurovision, while also criticizing pro-Palestinian…
Continue Reading
-
Fonseca's rise continues, wins biggest career title in Basel – ATP Tour
- Fonseca’s rise continues, wins biggest career title in Basel ATP Tour
- Joao Fonseca vs Jaume Munar Preview: Head-to-Head and Prediction for Swiss Indoors Basel 2025 PFSN
- Tennis, ATP – Swiss Indoors 2025: Davidovich Fokina takes out Humbert
Continue Reading
